Stephen Koscumb
Overview
Explore the profile of Stephen Koscumb including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
73
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Paez-Escamilla M, Caplash S, Kalra G, Odden J, Price D, Marroquin O, et al.
J Ophthalmic Inflamm Infect
. 2023 Aug;
13(1):35.
PMID: 37589912
Purpose: Posterior uveitis is a common chorioretinal pathology affecting all ages worldwide and is a frequent reason for referral to the retina clinic. The spectrum of etiologies for uveitis is...
2.
Herpes zoster ophthalmicus: frequency and risk factors for developing uncommon ocular manifestations
Dmitriev A, Odden J, Mora-Boellstorff D, Kinchington P, Sheridan K, Viehman J, et al.
Can J Ophthalmol
. 2023 May;
59(3):201-207.
PMID: 37192736
Objective: To determine the frequency of herpes zoster ophthalmicus (HZO) and assess risk factors for developing uncommon ocular manifestations of laboratory-verified HZO. Design: Retrospective cohort study. Methods: The frequency of...
3.
Gilmer G, Jackson N, Koscumb S, Marroquin O, Sowa G
Am J Phys Med Rehabil
. 2022 Mar;
102(1):34-42.
PMID: 35302527
Objective: To describe the demographic characteristics of patients who used telemedicine and office visits in physical medicine and rehabilitation during the COVID-19 pandemic and to quantify differences in clinical utilization...
4.
Bariola J, McCreary E, Wadas R, Kip K, Marroquin O, Minnier T, et al.
Open Forum Infect Dis
. 2021 Jul;
8(7):ofab254.
PMID: 34250192
Background: Monoclonal antibody treatment may prevent complications of coronavirus disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at...
5.
Huang D, McCreary E, Bariola J, Wadas R, Kip K, Marroquin O, et al.
Trials
. 2021 May;
22(1):363.
PMID: 34034784
Objectives: The primary objective is to evaluate the comparative effectiveness of COVID-19 specific monoclonal antibodies (mABs) with US Food and Drug Administration (FDA) Emergency Use Authorization (EUA), alongside UPMC Health...
6.
Bailes A, Navlani R, Koscumb S, Malecky A, Marroquin O, Wasan A, et al.
Spine J
. 2021 Mar;
21(9):1440-1449.
PMID: 33785473
Background Context: Psychological comorbidities are important prognostic factors for low back pain (LBP). To develop improved treatment paradigms, it is first necessary to characterize and determine current patterns of treatment...
7.
Johnson A, Adhikari S, Althouse A, Thoma F, Marroquin O, Koscumb S, et al.
Pacing Clin Electrophysiol
. 2018 Jul;
41(9):1150-1157.
PMID: 29959781
Background: Clinical guidelines recommend cardioverter defibrillator implantation for patients with heart failure and reduced ejection fraction. Despite this, women and minorities have been less likely to receive implantable cardioverter-defibrillator (ICD)...